• News Archive
  • Simaster
  • Webmail
  • Directory
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • News Report
  • Malaria Case in Indonesia is still High

Malaria Case in Indonesia is still High

  • 04 January 2016, 11:23 WIB
  • By: Teguh
  • 3304
  • PDF Version

Malaria is one of the deadliest diseases in the world. WHO data 2014 recorded 198 million cases of malaria occured globally and caused the death of 584,000 people in 2013. Malaria infections occurred in many parts of the world, especially in the tropics and sub-tropics countries, including Indonesia.

In Indonesia, about 35 percent of the population live in high risk area of malaria and reported as many as 38 thousand people die each year because of severe malaria due to Plasmodium falciparum. Outbreaks of malaria occur almost every year in various endemic regions in Indonesia. Several areas have been categorized as a red zone area of malaria such as East Nusa Tenggara, West Nusa Tenggara, Maluku, North Maluku, Central Borneo, Bangka Belitung, Riau, Bengkulu, Jambi, Central Sulawesi, West Sulawesi, Gorontalo and Aceh.

“Among 293 districts/cities in Indonesia, 167 of them are in the high risk area," said dr. Arend Laurence Mapanawang, Sp.Pd., FINASIM., Thursday (31/12) at his open examination of doctoral program at the Faculty of Medicine UGM.

Arend said that artemisinin-based combination therapy (ACT) is a widely-used therapy in the treatment of patients infected with plasmodium falciparum. In 2010, WHO reported that the implementation of ACT can reduce malaria cases globally. However, this therapy has not yet been successful for treating patients with malaria in some areas in Thailand and Cambodia.

ACT treatment failure prompted the WHO to improve the treatment with a combination of dehidroartemisinin and piperaquine (DHP). As a result, this therapy shows efficacy in the treatment of malaria. Nevertheless, this therapy has not been able to have a pharmacological effect or maximum cure rates and is still at risk for recurrence.

dr. Arend, the Chairman of STIKES Halamahera, said that the treatment of malaria in Indonesia is by implementing the combination of DHP with the addition of primaquine. Programmed therapy recommended by Permenkes in 2013 has been applied in Halmahera. Application of this combination therapy is due to the fact that Halmahera is one of high risk area for Malaria. However, the success rate of DHP combination and primaquine for malaria patients is increasing.

Therefore, Arend tested the pharmacokinetics of treatment with a combination dehidroartemisinin, piperaquine and primaquine. The result is combination of DHA ACT, piperaquine and primakuen is very effective for treating uncomplicated falciparum malaria patients. Patients treated with DHP and primaquine combination therapy showed a cure rate of 100 percent. While the DHP therapy for falciparum malaria cure rate reaches 95 percent or still has a cumulative risk of relapse by 5 percent.

"So far no studies showed resistance to the drug combination," he explained. (UGM / Ika)

Related News

  • Malaria Case in Indonesia is still High

    Monday,04 January 2016 - 11:23
  • Fitri Jamil Obtains Doctorate for Research on Malaria Falciparum

    Friday,23 September 2016 - 14:45
  • Remote Sensing Image Can be Used for Areas Vulnerable to Communicable Diseases

    Wednesday,04 May 2016 - 17:12
  • Dengue Case Can Be Predicted by Modelling

    Wednesday,18 July 2018 - 14:22
  • People Awareness Key to Mosquito Eradication

    Friday,25 August 2017 - 9:58

News Releases

  • UGM Researchers Breed New Black Soybean Cultivar 17 May 2022
    A team of researchers at the UGM Faculty of Agriculture is
    Salma
  • UGM Inaugurates New Professor of Chemical Engineering 13 May 2022
    Universitas Gadjah Mada (UGM) celebrated the promotion of
    Salma
  • UGM Among World’s 10 Best Universities to Deliver SDG 1 10 May 2022
    Universitas Gadjah Mada (UGM) was ranked in the top 10 glo
    Salma
  • UGM Receives WIPO IP Enterprise Medal 29 April 2022
    Universitas Gadjah Mada (UGM) has picked up the WIPO IP En
    Salma
  • Regulatory Sandbox for Health Technology 28 April 2022
    A team of UGM researchers led by Dr. E. Elsa Herdiana Murh
    Salma

Info

  • Install Fest Windows
    29 September 2017
  • Streaming Author Workshop Writing and Publishing
    14 July 2017
  • Hokkaido University Short Term Exchange Program HUSTEP
    08 January 2016
  • 2016 Amgen Scholars Program in Japan
    08 January 2016
  • Jardine Foundation Scholarship for Postgraduate Studies at University of Oxford and University of Cambridge
    01 July 2015

Event

  • 30May International Academic Conference on Tourism (INTACT) 2022 ...
  • 21Jul The International Conference on Sustainable Environment, Agriculture, and Tourism (ICOSEAT)...
  • 07Sep The 8th International Conference on Science and Technology (ICST 2022)...
Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2022 Universitas Gadjah Mada

PRIVACY POLICYCONTACT